{"id":"W4391779877","doi":"10.1038/s41591-024-02808-y","title":"Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial","year":2024,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; William Osler Health System; Centre Hospitalier de l’Université de Montréal; University of Toronto; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"Daiichi Sankyo Europe; Chugai Pharmaceutical; University of Texas MD Anderson Cancer Center; EMD Serono; Foundation Medicine; Karl Landsteiner Privatuniversität für Gesundheitswissenschaften; Universitätsklinikum Heidelberg; Ipsen; Deutsches Zentrum für Lungenforschung; Ottawa Hospital Research Institute; Seoul National University Hospital; Eisai; Universität Wien; PharmaMar; Institut Bergonié; Seoul National University; University of Toronto; Sanofi; Sungkyunkwan University; College of Medicine, Seoul National University; Genentech; Institut Gustave-Roussy; EpicentRx; Pfizer; Incyte; Mirati Therapeutics; Teva Pharmaceutical Industries; University of Ottawa; Johns Hopkins University; Nationales Centrum für Tumorerkrankungen Heidelberg; Amgen; Deutsches Krebsforschungszentrum; Université de Montréal; Samsung; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Regeneron Pharmaceuticals","keywords":"Durvalumab; Medicine; Immunotherapy; Oncology; Internal medicine; Lung cancer; Cancer; Immunology; Cancer research; Nivolumab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001870969,0.001194288,0.001935728,0.0003838741,0.0003054931,0.001042251,0.001149564,0.0009515614,0.003150266],"category_scores_gemma":[0.0006447914,0.0004321408,0.001039559,0.0003255612,0.0006161483,0.0007838036,0.000410542,0.00236971,0.0006709331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001783906,"about_ca_system_score_gemma":0.001230478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001972062,"about_ca_topic_score_gemma":0.007735468,"domain_scores_codex":[0.9995731,0.0002286357,0.0000135115,0.00006462423,0.00003521456,0.00008492274],"domain_scores_gemma":[0.9995933,0.00006647571,0.00007042237,0.0000435038,0.00002165728,0.0002045826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5602866,0.04902083,0.01160793,0.0009973116,0.00204051,0.0004866394,0.0004179394,0.003572089,0.06165168,0.0008585638,0.01186794,0.2971919],"study_design_scores_gemma":[0.6351225,0.3229377,0.02011534,0.00008969937,0.0008388683,0.0005256915,0.0001339067,0.00377011,0.00829874,0.0003291194,0.007789278,0.00004898358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991725,0.003640202,0.0003096164,0.0006962845,0.00016125,0.0007754799,0.0005903266,0.0001060079,0.001995851],"genre_scores_gemma":[0.9847596,0.003365861,0.002206281,0.001314042,0.0002049461,0.001011839,0.001990317,0.00004325001,0.005103851],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003150266,"threshold_uncertainty_score":0.01294321,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01803103236702123,"score_gpt":0.3536915487600901,"score_spread":0.3356605163930689,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}